Reckitt Benckiser increases its 2018 interim dividend by 6%
Reckitt Benckiser 2018 Interim results
Pro-forma growth in Q2 of +5%. Growth was volume led at +3%, with +2% from price / mix. IFCN grew by +9% on a pro-forma basis, driven by strong market growth and further operational improvements.
LFL growth in Q2 of +4%, with Health +3% and Hygiene Home +4%. Growth +3% volume, +1% price/mix, reflecting the lapping of the cyber-attack impact last year.
MJN integration into our Health Business Unit (BU) is on track. Strong top line growth combined with 2018 year-to-date synergies of £55m ($75m). We remain on track to achieve our increased synergies of $300m.
RB 2.0 progressing well. Management structure in place from January 2018. Work to complete all infrastructure changes by mid-2020 remains on track.
Adjusted operating margin was 23.6%. +50bps on a pro-forma basis and a decline of -30bps on a reported basis.
The Board declares an interim dividend of 70.5p per share (2017: 66.6p), an increase of +6%.
Full year net revenue target increased from +13-14% to +14-15% driven by IFCN growth exceeding expectations. No change in operating margin expectation.
Shoe Zone 2018 final results
Workspace 2019 interim resultsRead more
Avon Rubber 2018 final resultsRead more
Adept technology 2019 interim resultsRead more
Land Securities 2018 interim resultsRead more
B&M European value retail 2019 interim resultsRead more
Softcat 2018 final resultsRead more
Bellway 2018 final resultsRead more